Veekayem Fashion Reports 20 Percent Profit Growth in H1 FY 2025

Mumbai (Maharashtra) [India], December 26: Veekayem Fashion and Apparels Limited, an NSE-listed leading player in the textiles segment, registered a robust growth of 20% in the first half of the current financial year.

Mumbai-headquartered Veekayem Fashion and Apparels reported a net profit of Rs. 296.67 lakh for the six months ended September 2024 as compared with Rs. 247.57 lakh in the corresponding period of the previous financial year. The EPS for the period was Rs. 5.05 as against Rs. 4.21 last year.

Total revenue for the six-month period ended September 2024 was Rs. 12,290.45 lakh as compared with Rs. 14,972.75 lakh for the same period in the previous year, a decline of 17.9%.

Commenting on the results, Krishankant Gupta, Managing Director, Veekayem Fashion and Apparels Limited, said, “We are happy with the financial performance in the first half of the financial year 2024-25. Despite challenging market conditions, we have reported strong growth in net profit and other financial parameters. We are well-positioned to build on our performance in the second half of the year and the coming quarters.”

Established in 1985, Veekayem Fashion and Apparels Limited has established itself as a leader in the textile industry. It has a strong presence in suitings, shirtings, home furnishings, yarn, and garments segments. Some of its products include shirts, denims, trousers, T-shirts, jackets, pullovers, shorts, and accessories for men, women and kids. The company uses the latest machinery and technologies to ensure standard quality across its product range.

On Tuesday, the shares of Veekayem Fashion and Apparels Limited were trading at Rs. 224.90 on the NSE Emerge, giving it a market cap of just over Rs. 132 crore. The 52-week high and low of the shares are Rs. 337.95 and Rs. 72 respectively.

Some of the key clients of Veekayem Fashion and Apparels include Indian Terrain, Raymond, Pantaloons, Peter England, Scullers, Siyaram’s, Blackberry’s, Excalibur and Arrow, among others.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

One Analyst, 71,000 Investors: Why Ankit Jaiswal Built NiveshX

Bengaluru (Karnataka) [India], October 29: Your groceries arrive in 20 minutes. Biryani at midnight takes 30. Yet for most Indian investors, honest research on the stock they are about to…

CivitTDRx Enables a Digital-First Approach to Transparent TDR Transactions

New Delhi [India], October 29: SoftTech Engineers Limited, a pioneer in AECO (Architecture, Engineering, Construction & Operations) technology and e-governance solutions, has introduced CivitTDRx — a digital TDR exchange solution…

You Missed

Bollywood Actor Kamlesh Sawant Takes On India’s English-Speaking Challenge in New MySivi Ad

Bollywood Actor Kamlesh Sawant Takes On India’s English-Speaking Challenge in New MySivi Ad

One Analyst, 71,000 Investors: Why Ankit Jaiswal Built NiveshX

One Analyst, 71,000 Investors: Why Ankit Jaiswal Built NiveshX

CivitTDRx Enables a Digital-First Approach to Transparent TDR Transactions

CivitTDRx Enables a Digital-First Approach to Transparent TDR Transactions

World Book of Records (UK) Awards & Summit in Tunisia Celebrates Global Excellence with 50 Countries and Silver Jubilee of International Siddhashram Shakti Centre, UK

World Book of Records (UK) Awards & Summit in Tunisia Celebrates Global Excellence with 50 Countries and Silver Jubilee of International Siddhashram Shakti Centre, UK

Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52 percent Y-o-Y

Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52 percent Y-o-Y

AtHomeCare™ Trialling Integrated App to Streamline Post-Discharge Care, Reduce Readmissions

AtHomeCare™ Trialling Integrated App to Streamline Post-Discharge Care, Reduce Readmissions